IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Invus Financial Advisors, LLC

Q4 2019 Holdings

Filed 2020-02-13 | 5 holdings | $18.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Arcus Biosciences Inc(RCUS)COM03969F109$18.6M1,842,07799.0%
Oyster Point Pharma IncCOM69242L106$63.3K2,590,0150.3%
Yext Inc(YEXT)COM98585N106$59.8K4,146,7840.3%
Novocure Ltd(NVCR)ORD SHSG6674U108$39.7K470,8840.2%
Unity Biotechnology IncCOM91381U101$15.8K2,189,9980.1%